The purpose of this study to find out if enzalutamide, alone or combined with mifepristone, is effective in treating a specific type of breast cancer in comparison with standard chemotherapy with carboplatin, paclitaxel, capecitabine, or eribulin. The specific type of breast cancer include Triple-negative or ER/PgR-low and Androgen receptor positive breast cancer.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Yara Abdou
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Breast)
24-0602